1,2-Dihydro-5-imidazo[1,2-伪]pyridin-6-yl-6-methyl-2-oxo-3-pyridinecarbonitrile

This is the chemical nomenclature of 1,2-dihydro-5-imidazolo [1,2-β] pyridine-6-yl-6-methyl-2-oxo-3-pyridinecarbonitrile. To clarify its chemical structure, it should be analyzed by modern chemical methods. Looking at its name, it can be deduced that its structure is composed of several parts.
imidazolo [1,2-β] pyridine part is a nitrogen-containing heterocyclic structure, which is one of the core skeletons. 1,2-dihydro indicates that the double bond between the 1 and 2 positions of the heterocyclic ring is hydrogenated, and it is partially saturated. 5-Imidazolo [1,2-β] pyridine-6-yl, indicating that this heterocycle is connected to other structures at position 5, and position 6 is the check point for substituent connection.
6-methyl-2-oxo-3-pyridinecarbonitrile part, the pyridine ring is also an important structure. There is a methyl substitution at position 6, a carbonyl oxygen atom at position 2, and a methonitrile group at position 3. In this structure, the pyridine ring and the imidazolo-pyridine ring are related to each other to construct the overall chemical structure. The analysis of the chemical structure of
requires the rules of organic chemistry to clarify the positions and relationships of each part in the form of atomic connections and valence bonds. The complexity of the structure of this compound stems from the combination of polycyclic structures and different substituents, and the mutual influence of each part gives it unique chemical properties and reactivity.
Although it is expressed in ancient Chinese, the solution of the chemical structure ultimately requires the modern chemical knowledge system to accurately grasp the bonding between atoms, spatial arrangement and other elements in order to understand the delicacy of its structure.

1% 2C2 - Dihydro - 5 - imidazo% 5B1% 2C2 - β% 5Dpyridin - 6 - yl - 6 - methyl - 2 - oxo - 3 - pyridinecarbonitrile is an organic compound. Looking at its structure, its physical properties can be inferred.
This compound contains functional groups such as nitrile (-CN) and carbonyl (C = O). The nitrile group has a certain polarity, and the carbonyl group is also a polar group. The coexistence of the two makes the compound have a certain polarity. Therefore, it may have good solubility in polar solvents such as alcohols and ketones, but poor solubility in non-polar solvents such as alkanes. < Br >
There are van der Waals forces and hydrogen bonds between molecules. Because of electronegative atoms such as nitrogen and oxygen, intermolecular hydrogen bonds can be formed, which affects their melting and boiling points. Generally speaking, hydrogen bonds will increase the melting and boiling point. Therefore, the melting and boiling point of the compound may be relatively high, and the specific value needs to be accurately determined experimentally.
It is inferred from the appearance that if there is no conjugate system to cause color change, it may be a colorless to light yellow solid. Due to the rigid molecular structure, the molecular arrangement or relatively regular, it is more likely to be a solid state.
In addition, its density may be similar to that of common organic compounds, but the exact value also needs to be measured experimentally. In summary, due to the interaction between functional groups and molecules, the compound has a certain polarity, a high melting boiling point, or is a colorless to light yellow solid. Its solubility is affected by the polarity of the solvent, and its density is comparable to that of common organic compounds.

1% 2C2-dihydro-5-imidazolo [1,2-ethyl] pyridine-6-yl-6-methyl-2-oxo-3-pyridinecarbonitrile is a complex organic compound. Looking at its structure, it must have extraordinary uses.
In the field of pharmaceutical research and development, organic compounds may play a key role. Organic compounds are often the cornerstones of drug creation due to their unique chemical structures or specific biological activities. This compound has a delicate structure and may interact with specific targets in organisms. For example, it can act on the activity check point of some pathogenic proteins, like a delicate key matching a specific lock, inhibiting the abnormal function of the protein, thus providing the possibility of treating diseases. It may be able to target specific types of tumor cells, interfere with their signaling pathways, inhibit the growth and spread of tumor cells, and become a potential lead compound for the development of anti-cancer drugs.
In the field of materials science, it may also emerge. Organic compounds can be cleverly designed and synthesized to give materials unique properties. The special structure of this compound may give the material good photoelectric properties. If applied to photoelectric materials, it may improve the material's light absorption and conversion efficiency, just like adding a pair of keen "eyes" to photoelectric materials, better capture light energy and convert it into electricity, which has potential application value in the field of solar cells; or in the field of luminescent materials, it shows unique luminescent properties, providing new ideas for the development of new luminescent materials.
Furthermore, in the basic field of chemical research, this compound can provide an example for organic synthetic chemistry research. The construction of its complex structure requires delicate synthesis strategies and superb experimental skills. By exploring its synthesis path, chemists can develop new organic synthesis methods and technologies, just like opening up new chemical "waterways", promoting the continuous development of organic synthetic chemistry and laying the foundation for the creation of more complex organic compounds.

To prepare 1% 2C2-dihydro-5-imidazolo [1% 2C2-β] pyridine-6-yl-6-methyl-2-oxo-3-pyridineformonitrile, there are three methods.
First, start with pyridine derivatives. First take a specific pyridine compound, put it in a suitable reactor, add an appropriate amount of alkali as a catalyst, such as potassium carbonate, dissolve it into a suitable organic solvent, such as N, N-dimethylformamide, heat it up to a certain extent, about 60 to 80 degrees Celsius, slowly drop it into the reactant containing imidazole structure, after a few times of reaction, until the reaction is complete, cool it, pour it into ice water, adjust the pH to neutral with dilute acid, filter it, and the filter cake is recrystallized and refined to obtain the target product. This process requires attention to precise temperature regulation to prevent side reactions from breeding.
Second, starting from imidazole derivatives. Select the appropriate imidazole starter, place it in the reaction vessel, add acid catalysis, such as p-toluenesulfonic acid, and reflux the reaction in a solvent such as toluene. During this period, water is continuously removed to promote the right shift of the reaction. After the reaction is completed, cool, neutralize with alkali solution, separate the liquid, and the organic phase is dried and concentrated, and then separated by column chromatography to obtain a purified product. This path requires attention to the fine operation of water removal efficiency and separation steps.
Third, the method of cyclization is adopted. Using linear compounds containing pyridine and imidazole structure fragments as raw materials, adding metal catalysts, such as copper salts, with ligand assistance, in a specific solvent, such as 1,4-dioxane, heated to 100 to 120 degrees Celsius. After the reaction is completed, the filtrate is cooled, filtered, and concentrated, and recrystallized with a suitable solvent to obtain the required 1% 2C2-dihydro-5-imidazolo [1% 2C2-β] pyridine-6-yl-6-methyl-2-oxo-3-pyridineformonitrile. This method requires harsh catalyst and reaction conditions and requires fine control.

1% 2C2 - Dihydro - 5 - imidazo% 5B1% 2C2 - β% 5Dpyridin - 6 - yl - 6 - methyl - 2 - oxo - 3 - pyridinecarbonitrile is a chemical that is often involved in the field of medical research. However, it is difficult to generalize the potential side effects and risks, depending on their specific uses and mechanisms of action.
In pharmacological research, many compounds have therapeutic potential, but may lead to various adverse reactions. For example, in the experimental stage of animals, some similar structural compounds may affect the physiological functions of experimental animals, or cause digestive system disorders, such as nausea, vomiting, and diarrhea, which are caused by the drug interfering with the normal peristalsis of the gastrointestinal tract and the secretion of digestive juices; or affect the nervous system, causing dizziness, drowsiness, and fatigue, because the drug acts on neurotransmitter metabolism or nerve conduction pathways.
During clinical trials, some subjects also experience allergic reactions, such as rash, itching, and even shortness of breath and sudden drop in blood pressure, which is an excessive response of the human immune system to the compound. Long-term use of drugs containing this type of structure may cause chronic damage to liver and kidney function, because it is metabolized by the liver and excreted by the kidneys, and accumulates or exceeds the liver and kidney load for a long time.
However, the above side effects and risks are only speculated based on similar compounds, 1% 2C2 - Dihydro - 5 - imidazo% 5B1% 2C2 - β% 5Dpyridin - 6 - yl - 6 - methyl - 2 - oxo - 3 - pyridinecarbonitrile The exact potential effects need to be further investigated by experiments and clinical studies.